JG
Jefferies Group Portfolio holdings
AUM
$3.42B
1-Year Return
1.45%
This Quarter Return
+2.21%
1 Year Return
-1.45%
3 Year Return
+33.54%
5 Year Return
+41.04%
10 Year Return
–
AUM
$3.94B
AUM Growth
-$412M
(-9.5%)
Cap. Flow
-$911M
Cap. Flow
% of AUM
-23.14%
Top 10 Holdings %
Top 10 Hldgs %
11.78%
Holding
2,074
New
453
Increased
485
Reduced
481
Closed
439
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$66.1M |
| 2 |
NXP Semiconductors
NXPI
|
+$40.1M |
| 3 |
AMRN
Amarin Corp
AMRN
|
+$33.1M |
| 4 |
Alibaba
BABA
|
+$25.4M |
| 5 |
Wells Fargo
WFC
|
+$23.1M |
Top Sells
| 1 |
Automatic Data Processing
ADP
|
+$180M |
| 2 |
Bank of America
BAC
|
+$146M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$59.5M |
| 4 |
CELG
Celgene Corp
CELG
|
+$54.8M |
| 5 |
Avis
CAR
|
+$35.2M |
Sector Composition
| 1 | Technology | 11.41% |
| 2 | Healthcare | 11.31% |
| 3 | Consumer Discretionary | 11.02% |
| 4 | Industrials | 9.7% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
MYR Group
MYRG
$2.71B
| $202K | ﹤0.01% |
+6,189
| New | +$202K |
|
1277
Neogen
NEOG
$1.24B
| $201K | ﹤0.01% |
+5,622
| New | +$201K |
|
1278
Nu Skin
NUS
$574M
| $201K | ﹤0.01% |
2,440
-3,848
| -61% | -$317K |
|
|
UBA
1279
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $201K | ﹤0.01% |
+9,430
| New | +$201K |
|
|
FNSR
1280
DELISTED
Finisar Corp
FNSR
| $201K | ﹤0.01% |
10,544
-5,675
| -35% | -$108K |
|
1281
TechTarget
TTGT
$423M
| $200K | ﹤0.01% |
+10,285
| New | +$200K |
|
1282
Bloomin' Brands
BLMN
$588M
| $199K | ﹤0.01% |
+10,070
| New | +$199K |
|
1283
Rambus
RMBS
$8.02B
| $197K | ﹤0.01% |
+18,075
| New | +$197K |
|
|
AVP
1284
DELISTED
Avon Products, Inc.
AVP
| $197K | ﹤0.01% |
89,734
+2,914
| +3% | +$6.4K |
|
1285
Akebia Therapeutics
AKBA
$795M
| $193K | ﹤0.01% |
21,815
-11,685
| -35% | -$103K |
|
1286
Knowles
KN
$1.83B
| $193K | ﹤0.01% |
+11,583
| New | +$193K |
|
1287
Telephone and Data Systems
TDS
$4.43B
| $193K | ﹤0.01% |
6,332
-52,371
| -89% | -$1.6M |
|
|
FPRX
1288
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $191K | ﹤0.01% |
+13,704
| New | +$191K |
|
1289
Novavax
NVAX
$1.29B
| $188K | ﹤0.01% |
5,004
+4,439
| +786% | +$167K |
|
1290
Quanex
NX
$701M
| $186K | ﹤0.01% |
+10,200
| New | +$186K |
|
1291
Intrepid Potash
IPI
$380M
| $185K | ﹤0.01% |
+5,154
| New | +$185K |
|
|
MDR
1292
DELISTED
McDermott International
MDR
| $185K | ﹤0.01% |
+10,053
| New | +$185K |
|
1293
e.l.f. Beauty
ELF
$7.88B
| $183K | ﹤0.01% |
+14,343
| New | +$183K |
|
1294
Gannett
GCI
$601M
| $182K | ﹤0.01% |
11,569
-60,931
| -84% | -$959K |
|
1295
CME Group
CME
$94.3B
| $178K | ﹤0.01% |
1,043
-36,552
| -97% | -$6.24M |
|
1296
Stagwell
STGW
$1.42B
| $178K | ﹤0.01% |
42,929
+21,429
| +100% | +$88.9K |
|
1297
Inovio Pharmaceuticals
INO
$146M
| $174K | ﹤0.01% |
+2,613
| New | +$174K |
|
|
CNCE
1298
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $174K | ﹤0.01% |
+11,699
| New | +$174K |
|
1299
Titan International
TWI
$534M
| $172K | ﹤0.01% |
23,176
-1,706
| -7% | -$12.7K |
|
1300
Accuray
ARAY
$180M
| $168K | ﹤0.01% |
37,400
+6,000
| +19% | +$27K |
|